Showing results (231-240 of 246) with videos related to

Sort By:
Pageof 25
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2016
rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous SystemSeemin Seher Ahmed, Stefan A Schattgen, Ashley E Frakes, et al.
Plos Biology|March 24, 2026
A quantitative cell-based reporter links TDP-43 aggregation and dysfunction to define pathogenic mechanismsLohany Dias Mamede, Miwei Hu, Jaime Vaquer-Alicea, et al.
Journal of Alzheimer'S Disease : JAD|February 16, 2011
Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease miceValentina Echeverria, Ross Zeitlin, Sarah Burgess, et al.
Current Alzheimer Research|June 10, 2008
Fiber diffraction as a screen for amyloid inhibitorsDaniel A Kirschner, Abby A R Gross, Marla M Hidalgo, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 24, 2006
Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic miceLawrence Wrabetz, Maurizio D'Antonio, Maria Pennuto, et al.
The Journal of Clinical Investigation|April 26, 2014
Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelinationTiago Ferreira da Silva, Jessica Eira, André T Lopes, et al.
Journal of Structural Biology|December 11, 2007
Peripheral myelin of Xenopus laevis: role of electrostatic and hydrophobic interactions in membrane compactionXiaoYang Luo, Jana Cerullo, Tamara Dawli, et al.
The Journal of Biological Chemistry|November 16, 2005
Gerstmann-Sträussler-Scheinker disease amyloid protein polymerizes according to the "dock-and-lock" modelMarco Gobbi, Laura Colombo, Michela Morbin, et al.
Frontiers in Neurology|September 28, 2020
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1ADavide Visigalli, Giovanna Capodivento, Abdul Basit, et al.
Molecular Cell|February 9, 2021
Neuronal non-CG methylation is an essential target for MeCP2 functionRebekah Tillotson, Justyna Cholewa-Waclaw, Kashyap Chhatbar, et al.
Pageof 25